Provided by Tiger Trade Technology Pte. Ltd.

Apellis Pharmaceuticals Inc.

19.86
-0.3000-1.49%
Post-market: 19.860.00000.00%16:55 EST
Volume:2.88M
Turnover:57.26M
Market Cap:2.54B
PE:115.19
High:20.32
Open:20.32
Low:19.55
Close:20.16
52wk High:30.48
52wk Low:16.10
Shares:127.83M
Float Shares:78.12M
Volume Ratio:1.52
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1724
EPS(LYR):0.1724
ROE:7.48%
ROA:3.53%
PB:6.86
PE(LYR):115.19

Loading ...

Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 01, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 15, 2023

Major Issues Report

8-K - Current report
Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans